Drugs / Reduning injection
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07126171 | Aug → Nov 2025 overdue | chikungunya | Jiangsu Kanion Pharmaceutical Co., Ltd | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Reduning injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07126171 ↗ |
| Route | Intravenous | “intravenous drip” NCT07126171 ↗ |